Clinical Trials Directory

Trials / Completed

CompletedNCT05916209

PENG and LFCN Block Versus FIC Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis

Pericapsular Nerve Group (PENG) Block and Lateral Femoral Cutaneous Nerve (LFCN) Block Versus Fascia Iliaca (FIC) Block for Multimodal Analgesia After Total Hip Replacement Surgery: a Retrospective Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Ospedale Edoardo Bassini · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Background: Optimal pain control with limited muscle weakness is paramount for a swift initiation of physical therapy and ambulation. Fascia iliaca compartment block (FICB) has been recommended since it offers the best pain control with low risk of motor block. Pericapsular nerve group block (PENG) with lateral femoral cutaneous nerve (LFCN) block has been proposed as an effective alternative to FICB that offers similar pain control with a considerably lower risk of motor block. This study aimed to compare the afore mentioned blocks and determine which one yielded the lowest NRS score.

Detailed description

This single-center, retrospective investigation was conducted at ASST Nord Milano Bassini hospital. The study was approved by the ethics committee "Comitato Etico Milano Area 3". The main outcome of the study was the comparison of postoperative pain at 6, 12 and 24 hours, expressed as NRS (numeric rating scale), between PENG and LCFN . Secondary outcomes included total opioid consumption expressed as milligrams of morphine equivalents (MME), time to first opioid request, time to first postoperative ambulation.

Conditions

Interventions

TypeNameDescription
PROCEDUREPeripheral nerve blocksPeripheral nerve blocks provide intense, site-specific analgesia administring local anesthetics near the nerves.

Timeline

Start date
2023-02-01
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2023-06-23
Last updated
2023-06-23

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05916209. Inclusion in this directory is not an endorsement.